Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery
- PMID: 10671906
- PMCID: PMC2014896
- DOI: 10.1046/j.1365-2125.2000.00129.x
Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery
Abstract
Aims: Vasoconstriction in human coronary artery can be mediated via activation of both 5-HT2 and 5-HT1B-receptors. Coronary vasoconstriction is a rare, but potential adverse effect of the antimigraine drug sumatriptan. In order to investigate the receptor population involved we compared the vasoconstrictor effects of sumatriptan (a mixed 5-HT1B/1D-receptor agonist) with those of L-775, 606 (a selective 5-HT1D-receptor agonist) and 5-HT (the endogenous ligand) in human isolated coronary arteries.
Methods: Coronary arteries were obtained from human hearts removed prior to transplant surgery. Several endothelium denuded ring segments (4 mm in length) were obtained from each artery and mounted for isometric tension recording. Each segment was first exposed to 45 mm KCl and then to 5-HT (1 nm-100 microm ). Concentration-effect curves to L-775,606 (1-(3-(5-(1,2, 4-triazol-4-yl)-1H-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)p ipe razine) and sumatriptan were then performed in a consecutive and random manner. The response to repeated application of 5-HT was obtained in separate segments.
Results: Twenty-five segments from seven different coronary arteries were studied. Concentration-effect curves were fitted to the data using nonlinear regression analysis. The maximum contraction for L-775,606 was significantly less than that for sumatriptan with Emax values (% relative to 45 mm KCl=100%) of 30.1+/-4.22 and 41.5+/-2.7, respectively. L-775,606 was significantly (30-fold) less potent than sumatriptan in causing contraction compared with sumatriptan (EC50 values were 6.0 microm and 0.2 microm, respectively). For comparison the Emax value for 5-HT was 77.2% and the EC50 value was 0.2 microm.
Conclusions: The selective 5-HT1D-receptor agonist L-775,606 has less propensity towards vasoconstriction in human isolated coronary artery (endothelium-denuded) than was mixed 5-HT1B/1D-receptor agonist sumatriptan. The contractions produced were at concentrations where L-775,606 would be expected to occupy 5-HT1B-receptors.
Figures

Similar articles
-
5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519.Br J Clin Pharmacol. 1996 Oct;42(4):431-41. doi: 10.1046/j.1365-2125.1996.04217.x. Br J Clin Pharmacol. 1996. PMID: 8904614 Free PMC article.
-
Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.Br J Pharmacol. 1997 Nov;122(5):875-84. doi: 10.1038/sj.bjp.0701470. Br J Pharmacol. 1997. PMID: 9384503 Free PMC article.
-
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.Eur J Pharmacol. 1999 May 7;372(1):49-56. doi: 10.1016/s0014-2999(99)00114-4. Eur J Pharmacol. 1999. PMID: 10374714
-
5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.Zhongguo Yao Li Xue Bao. 1999 Dec;20(12):1057-67. Zhongguo Yao Li Xue Bao. 1999. PMID: 11216445 Review.
-
Mechanisms of action of the 5-HT1B/1D receptor agonists.Arch Neurol. 2002 Jul;59(7):1084-8. doi: 10.1001/archneur.59.7.1084. Arch Neurol. 2002. PMID: 12117355 Review.
Cited by
-
Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics.Front Mol Neurosci. 2024 Feb 28;17:1355281. doi: 10.3389/fnmol.2024.1355281. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38481473 Free PMC article. Review.
-
Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors.J Headache Pain. 2022 Feb 17;23(1):26. doi: 10.1186/s10194-022-01394-z. J Headache Pain. 2022. PMID: 35177004 Free PMC article.
-
Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries.Eur J Clin Pharmacol. 2005 Nov;61(10):733-42. doi: 10.1007/s00228-005-0988-4. Epub 2005 Sep 8. Eur J Clin Pharmacol. 2005. PMID: 16151760 Clinical Trial.
-
Current and future strategies for targeting the endothelin pathway in cardiovascular disease.Nat Cardiovasc Res. 2023 Nov;2(11):972-990. doi: 10.1038/s44161-023-00347-2. Epub 2023 Nov 2. Nat Cardiovasc Res. 2023. PMID: 39196099 Review.
-
Beta-Blockers for Migraine Prevention: a Review Article.Curr Treat Options Neurol. 2019 Mar 23;21(4):20. doi: 10.1007/s11940-019-0556-3. Curr Treat Options Neurol. 2019. PMID: 30903383 Review.
References
-
- Lloyd DK, Simmons V. Adverse reactions associated with sumatriptan. Lancet. 1993;341:1092. - PubMed
-
- O’Connor P, Gladstone P. Oral sumatriptan-associated myocardial infarction. Neurol. 1995;45:2274–2276. - PubMed
-
- Ottervanger JP, Paalman JJA, Boxma GL, Stricker BHC. Transmural myocardial infarction with sumatriptan. Lancet. 1993;341:861–862. - PubMed
-
- Houghton LA, Foster JM, Whorwell PJ, Morris J, Fowler P. Is chest pain after sumatriptan oesophageal in origin. Lancet. 1994;344:985–986. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources